{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:44:03Z","timestamp":1790847843612,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.steroids.2017.07.006","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T12:32:18Z","timestamp":1500467538000},"page":"131-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Ferulic acid reverses depression-like behavior and oxidative stress induced by chronic corticosterone treatment in mice"],"prefix":"10.1016","volume":"125","author":[{"given":"Ana L\u00facia Bertarello","family":"Zeni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anderson","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Dalmagro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2017.07.006_b0005","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.paid.2016.11.049","article-title":"An investigation of vulnerability factors for depression","volume":"107","author":"Malinowski","year":"2017","journal-title":"Pers. Individ. Dif."},{"key":"10.1016\/j.steroids.2017.07.006_b0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrn1846","article-title":"New approaches to antidepressant drug discovery: beyond monoamines","volume":"7","author":"B. O., N. E.J.","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.steroids.2017.07.006_b0015","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.pbb.2012.09.011","article-title":"The role of the NMDA receptors and l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of duloxetine in the forced swimming test","volume":"103","author":"Zomkowski","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.steroids.2017.07.006_b0020","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0306-4522(03)00105-2","article-title":"Chronic stress attenuates glucocorticoid negative feedback: involvement of the prefrontal cortex and hippocampus","volume":"119","author":"Mizoguchi","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.steroids.2017.07.006_b0025","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1176\/appi.ajp.161.7.1309-a","article-title":"Untreated depression and hippocampal volume loss [5] (multiple letters)","volume":"161","author":"Carroll","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.steroids.2017.07.006_b0030","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.euroneuro.2007.05.002","article-title":"Neuroprotection by Imipramine against lipopolysaccharide-induced apoptosis in hippocampus-derived neural stem cells mediated by activation of BDNF and the MAPK pathway","volume":"18","author":"Peng","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.steroids.2017.07.006_b0035","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.pnpbp.2010.05.004","article-title":"A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness","volume":"35","author":"Maes","year":"2011","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry."},{"key":"10.1016\/j.steroids.2017.07.006_b0040","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neuint.2011.05.002","article-title":"Stress, glucocorticoids and glutamate release: effects of antidepressant drugs","volume":"59","author":"Musazzi","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.steroids.2017.07.006_b0045","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cbi.2016.07.006","article-title":"Hydrogen peroxide-induced oxidative damage in peripheral blood lymphocytes from rats chronically treated with corticosterone: the protective effect of oxytocin treatment","volume":"256","author":"Stani\u0107","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.steroids.2017.07.006_b0050","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00424-010-0809-1","article-title":"Glutamate receptors, neurotoxicity and neurodegeneration","volume":"460","author":"Lau","year":"2010","journal-title":"Pflugers Arch. Eur. J. Physiol."},{"key":"10.1016\/j.steroids.2017.07.006_b0055","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1007\/s12035-015-9182-6","article-title":"Agmatine, by improving neuroplasticity markers and inducing Nrf2, prevents corticosterone-induced depressive-like behavior in mice","volume":"53","author":"Freitas","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.steroids.2017.07.006_b0060","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neuropharm.2015.07.037","article-title":"Antidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: role of activity at NMDA receptor","volume":"99","author":"Sa\u0142at","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.steroids.2017.07.006_b0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neulet.2016.03.051","article-title":"Antidepressant-like effect of low dose ketamine and scopolamine co-treatment in mice","volume":"620","author":"Petryshen","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.steroids.2017.07.006_b0070","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neubiorev.2014.05.007","article-title":"Oxidative & nitrosative stress in depression: why so much stress?","volume":"45","author":"Moylan","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.steroids.2017.07.006_b0075","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1016\/j.febslet.2012.09.025","article-title":"Do antioxidants impair signaling by reactive oxygen species and lipid oxidation products?","volume":"586","author":"Niki","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.steroids.2017.07.006_b0080","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.pnpbp.2012.10.017","article-title":"Antioxidants as potential therapeutics for neuropsychiatric disorders","volume":"46","author":"Pandya","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.steroids.2017.07.006_b0085","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","article-title":"Increased Levels of Glutamate in Brains from Patients with Mood Disorders","volume":"62","author":"Hashimoto","year":"2007","journal-title":"Biol. Psychiatry."},{"key":"10.1016\/j.steroids.2017.07.006_b0090","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.biopha.2016.11.073","article-title":"The role of NMDA receptor and nitric oxide\/cyclic guanosine monophosphate pathway in the antidepressant-like effect of dextromethorphan in mice forced swimming test and tail suspension test","volume":"85","author":"Sakhaee","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.steroids.2017.07.006_b0095","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.fct.2013.12.024","article-title":"Ferulic acid: pharmacological and toxicological aspects","volume":"65","author":"Mancuso","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.steroids.2017.07.006_b0100","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.foodchem.2008.02.039","article-title":"Chemistry, natural sources, dietary intake and pharmacokinetic properties of ferulic acid: a review","volume":"109","author":"Zhao","year":"2008","journal-title":"Food Chem."},{"key":"10.1016\/j.steroids.2017.07.006_b0105","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.brainresbull.2011.07.002","article-title":"Ferulic acid-induced anti-depression and prokinetics similar to Chaihu-Shugan-San via polypharmacology","volume":"86","author":"jin Zhang","year":"2011","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.steroids.2017.07.006_b0110","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11011-014-9635-z","article-title":"Antidepressant-like effects of ferulic acid: involvement of serotonergic and norepinergic systems","volume":"30","author":"Chen","year":"2014","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.steroids.2017.07.006_b0115","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejphar.2011.12.041","article-title":"Ferulic acid exerts antidepressant-like effect in the tail suspension test in mice: evidence for the involvement of the serotonergic system","volume":"679","author":"Zeni","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.steroids.2017.07.006_b0120","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pbb.2012.08.020","article-title":"Involvement of PKA, CaMKII, PKC, MAPK\/ERK and PI3K in the acute antidepressant-like effect of ferulic acid in the tail suspension test","volume":"103","author":"Zeni","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.steroids.2017.07.006_b0125","first-page":"1559","article-title":"Potent protection of Danshensu 3-(3,4-dihydroxyphenyl-lactic acid) against excitotoxic effects of maternal intragastric administration of monosodium glutamate at a late stage of pregnancy on developing mouse fetal brain","volume":"5","author":"Shen","year":"2010","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.steroids.2017.07.006_b0130","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s11011-015-9725-6","article-title":"Ferulic acid chronic treatment exerts antidepressant-like effect: role of antioxidant defense system","volume":"30","author":"Lenzi","year":"2015","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.steroids.2017.07.006_b0135","article-title":"Ferulic acid exhibits antiepileptogenic effect and prevents oxidative stress and cognitive impairment in the kindling model of epilepsy","author":"Hassanzadeh","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.steroids.2017.07.006_b0140","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.physbeh.2016.12.003","article-title":"Elevation of synaptic protein is associated with the antidepressant-like effects of ferulic acid in a chronic model of depression","volume":"169","author":"Liu","year":"2017","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.steroids.2017.07.006_b0145","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejphar.2016.01.015","article-title":"Apigenin reverses depression-like behavior induced by chronic corticosterone treatment in mice","volume":"774","author":"Weng","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.steroids.2017.07.006_b0150","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3390\/molecules21101341","article-title":"Resveratrol ameliorates the depressive-like behaviors and metabolic abnormalities induced by chronic corticosterone injection","volume":"21","author":"Li","year":"2016","journal-title":"Molecules."},{"key":"10.1016\/j.steroids.2017.07.006_b0155","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.nlm.2008.07.001","article-title":"Habituation to repeated stress: get used to it","volume":"92","author":"Grissom","year":"2009","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.steroids.2017.07.006_b0160","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.biopsych.2008.06.016","article-title":"Acute hippocampal brain-derived neurotrophic factor restores motivational and forced swim performance after corticosterone","volume":"64","author":"Gourley","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.steroids.2017.07.006_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2014.10.003","article-title":"Folic acid prevents depressive-like behavior induced by chronic corticosterone treatment in mice","volume":"127","author":"Rosa","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.steroids.2017.07.006_b0170","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.brainres.2008.12.083","article-title":"The varying effects of short-term and long-term corticosterone injections on depression-like behavior in mice","volume":"1261","author":"Zhao","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.steroids.2017.07.006_b0175","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.steroids.2015.01.021","article-title":"Effect of a novel 5-HT 3 receptor antagonist 4i, in corticosterone-induced depression-like behavior and oxidative stress in mice","volume":"96","author":"Gupta","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2017.07.006_b0180","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.steroids.2017.07.006_b0185","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jep.2011.07.009","article-title":"Antidepressant-like and neuroprotective effects of Aloysia gratissima: investigation of involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway","volume":"137","author":"Zeni","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.steroids.2017.07.006_b0190","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jpsychires.2011.11.009","article-title":"A.L. Severo Rodrigues, Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress","volume":"46","author":"Moretti","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.steroids.2017.07.006_b0195","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000087097","article-title":"Chronic mild stress (CMS) revisited: consistency and behavioural- neurobiological concordance in the effects of CMS","volume":"52","author":"Willner","year":"2005","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.steroids.2017.07.006_b0200","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.steroids.2017.07.006_b0205","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/cber.187901201117","article-title":"Bemerkungen zu der Abhandlung der HH. Weselsky und Benedikt\u202fUeber einige Azoverbindungen","volume":"12","author":"Griess","year":"1879","journal-title":"Berichte Der Dtsch. Chem. Gesellschaft"},{"key":"10.1016\/j.steroids.2017.07.006_b0210","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0076-6879(94)33041-7","article-title":"Oxygen radicals in biological systems part C","volume":"233","author":"Reznick","year":"1994","journal-title":"Meth. Enzymol."},{"key":"10.1016\/j.steroids.2017.07.006_b0215","first-page":"70","author":"Ellman","year":"1959","journal-title":"Tissue Sufhydryl Groups"},{"key":"10.1016\/j.steroids.2017.07.006_b0220","first-page":"220","article-title":"Protein measurement with the Folin phenol reagent","volume":"217","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.steroids.2017.07.006_b0225","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1017\/S1461145707008401","article-title":"Oxidative stress in psychiatric disorders: evidence base and therapeutic implications","volume":"11","author":"Ng","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.steroids.2017.07.006_b0230","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.pnpbp.2008.11.010","article-title":"In vivo antioxidant status: a putative target of antidepressant action","volume":"33","author":"Zafir","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.steroids.2017.07.006_b0235","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1046\/j.1471-4159.1994.63020596.x","article-title":"Physiological elevations of glucocorticoids potentiate glutamate accumulation in the hippocampus","volume":"63","author":"Stein-Behrens","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.steroids.2017.07.006_b0240","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrd2462","article-title":"Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders","volume":"7","author":"Sanacora","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.steroids.2017.07.006_b0245","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1523\/JNEUROSCI.5033-04.2005","article-title":"Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus","volume":"25","author":"Bonanno","year":"2005","journal-title":"J. Neurosci."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X17301204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X17301204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T00:21:01Z","timestamp":1535588461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X17301204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":49,"alternative-id":["S0039128X17301204"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2017.07.006","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ferulic acid reverses depression-like behavior and oxidative stress induced by chronic corticosterone treatment in mice","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2017.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}